Empire Life Investments Inc. boosted its position in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 9.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 423,163 shares of the medical equipment provider’s stock after purchasing an additional 35,972 shares during the quarter. Zimmer Biomet comprises approximately 3.9% of Empire Life Investments Inc.’s investment portfolio, making the stock its 3rd largest position. Empire Life Investments Inc. owned about 0.21% of Zimmer Biomet worth $51,063,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Longview Partners Guernsey LTD raised its stake in Zimmer Biomet by 6.9% in the 4th quarter. Longview Partners Guernsey LTD now owns 8,027,808 shares of the medical equipment provider’s stock valued at $968,716,000 after purchasing an additional 521,124 shares during the last quarter. Nordea Investment Management AB grew its holdings in Zimmer Biomet by 7.3% in the 3rd quarter. Nordea Investment Management AB now owns 5,277,660 shares of the medical equipment provider’s stock valued at $617,961,000 after buying an additional 357,302 shares in the last quarter. American Century Companies Inc. grew its holdings in Zimmer Biomet by 14.7% in the 4th quarter. American Century Companies Inc. now owns 4,777,397 shares of the medical equipment provider’s stock valued at $576,488,000 after buying an additional 612,044 shares in the last quarter. Jana Partners LLC grew its holdings in Zimmer Biomet by 16.6% in the 3rd quarter. Jana Partners LLC now owns 4,662,497 shares of the medical equipment provider’s stock valued at $545,932,000 after buying an additional 662,497 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Zimmer Biomet by 24.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 2,759,704 shares of the medical equipment provider’s stock valued at $323,134,000 after buying an additional 541,102 shares in the last quarter. 86.64% of the stock is owned by hedge funds and other institutional investors.
In other news, insider Bryan C. Hanson bought 25,077 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was bought at an average cost of $119.68 per share, for a total transaction of $3,001,215.36. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Chad F. Phipps sold 20,826 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $115.95, for a total value of $2,414,774.70. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.
Zimmer Biomet Holdings Inc (ZBH) opened at $120.86 on Monday. Zimmer Biomet Holdings Inc has a twelve month low of $108.03 and a twelve month high of $133.49. The company has a market capitalization of $24,552.33, a PE ratio of 15.05, a P/E/G ratio of 2.13 and a beta of 1.13. The company has a current ratio of 1.50, a quick ratio of 0.81 and a debt-to-equity ratio of 0.76.
Zimmer Biomet (NYSE:ZBH) last announced its earnings results on Tuesday, January 30th. The medical equipment provider reported $2.10 EPS for the quarter, meeting analysts’ consensus estimates of $2.10. Zimmer Biomet had a return on equity of 15.45% and a net margin of 23.51%. The company had revenue of $2.07 billion during the quarter, compared to analysts’ expectations of $2.03 billion. During the same period last year, the business posted $2.14 EPS. Zimmer Biomet’s revenue for the quarter was up 3.0% on a year-over-year basis. equities analysts anticipate that Zimmer Biomet Holdings Inc will post 7.8 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/12/zimmer-biomet-holdings-inc-zbh-is-empire-life-investments-inc-s-3rd-largest-position.html.
Zimmer Biomet Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.